Daré Bioscience, Inc. (DARE)
1.56
0.00 (0.00%)
USD |
NASDAQ |
Mar 04, 16:00
1.575
+0.02
(+0.96%)
After-Hours: 20:00
Daré Bioscience EPS Diluted (Quarterly) : -0.2793 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.563M |
| Revenue (Quarterly) | 0.0023M |
| Total Expenses (Quarterly) | 3.565M |
| Enterprise Value | 7.380M |
| Gross Profit Margin (Quarterly) | -26.55K% |
| Profit Margin (Quarterly) | -154.9K% |
| Earnings Yield | -114.3% |
| Normalized Earnings Yield | -114.16 |